Emanual Maverakis, M.D.

Emanuel Maverakis and his research team pursue a broad range of clinical and translational research interests, including immunotherapies for melanoma, T-cell-mediated skin diseases and murine models of autoimmunity. His work is supported by the Burroughs Wellcome Fund, the National Institutes of Health, the Department of Veterans Affairs and the Howard Hughes Medical Institute.

His research has been published in leading journals, including The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences and The Journal of Clinical Investigation.

Clinically, Maverakis specializes in the care of patients with severe immune-mediated systemic diseases affecting the skin.

Title: Professor/Professor in Residence

Undergraduate Education: University of California, Los Angeles in Los Angeles, CA, B.S., Summa Cum Laude

Medical Education: Harvard Medical School, Boston, MA, M.D., Summa Cum Laude

Fellowship: Howard Hughes Medical Institute Fellow, La Jolla Institute for Immunology, La Jolla, CA

Internship: Harvard's Beth Israel Deaconess Medical Center, Boston, MA, Internal Medicine

Residency: University of California, Davis in Davis, CA, Dermatology

A comprehensive list of Maverakis' publications can be found on PubMed®. 

Park D, Phoomak C, Xu G, Olney LP, Tran KA, Park SS, Haigh NE, Li Q, Shimoda M, Matoba N, Fierro F, Wongkham S, Merleev AA, Luxardi G, Maverakis E, Lebrilla CB. Metastasis of cholangiocarcinoma is promoted by extended high mannose glycans. Proceedings of the National Academy of Sciences USA. 2020 Apr 7;117(14):7633-7644

Merleev AA, Park D, Xie Y, Kailemia MJ, Xu G, Ruhaak LR, Kim K, Hong Q, Li Q, Patel F, Wan YY, Marusina AI, Adamopoulos IE, Lal NN, Mitra A, Le ST, Shimoda M, Luxardi G, Lebrilla CB, Maverakis E. A site-specific map of the human plasma glycome and its age and gender-associated alterations. Scientific Reports, 17505 (2020). (This manuscript is a comprehensive map of the human plasma glycome)

Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen MC, Guenova E, Dissemond J, Shinkai K, Langan SM. Pyoderma gangrenosum. Nature Reviews Disease Primers. 2020 Oct 8;6(1):81.

Khuat LT, Le CT, Pai CCS, Maverakis E, ... Murphy WJ. Obesity and Microbiome Alterations Augment Acute Gastrointestinal Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation. Science Translational Medicine. 2020.

Tuscano JM, Poh C, Kaesberg P, Luxardi G, Merleev A, Marusina A, Brunson A, Rosenberg A, Jonas B, Maverakis E. Rituximab and Lenalidomide followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma: Long-term Follow-up and Correlative Analysis. Clinical Cancer Research. 2021.

Patrick GJ, Liu H, Alphonse MP, Dikeman DA, Youn C, Otterson JC, Wang Y, … Maverakis E, Garza LA, Milner JD, Gao P, Ramanujam M, Raymond EL, Archer NK, and Miller LS. Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. Journal of Clinical Investigation. 2021 131(5)

Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris. New England Journal of Medicine. 2021 Jun 17;384(24):2295-2305

For more information or to schedule an appointment, please call 916-734-6111 or 800-770-9282.